The S&P 500 is flirting with what would be a rare accomplishment: rising 20% or more during two consecutive calendar years.
More Stories
Bristol-Myers Squibb stock jumps on schizophrenia drug approval
Bristol-Myers Squibb shares rose in premarket trade on Friday after the Food and Drug Administration approved a schizophrenia drug.
Chinese stocks could surge higher as investors get ‘FOMO,’ Goldman Sachs says
International investors are getting increasingly concerned about missing out on the rally that was sparked by the unveiling of the...
Actress Jameela Jamil and singer James Blake are still trying to sell their L.A. home—now for $6.35 million
The couple have cut the price of the 6,934-square-foot home yet again in the hopes of finally offloading it.
Billy Joel is finally selling his huge Florida mansion after 6 years of trying
Sitting on 1.61 acres, this Mediterranean-style beauty boasts a jaw-dropping 13,349 square feet of pure grandeur spread across 3 stories
German firm blames transcription error for discrepancy spotted by short seller
The German company under fire from a short seller on Friday said a transcription error was the cause for a...
Satellite-TV rivals DirecTV, Dish reportedly in advanced merger talks
The Wall Street Journal reported DirecTV could acquire rival Dish, creating one of the nation’s largest pay-TV providers, in a...